DALLAS, July 18, 2025 (GLOBE NEWSWIRE) -- NDBT (North Dallas Bank & Trust Co.), an independent community bank established in 1961, today announced net earnings for three months of $2,102,943 or $0.82 per share, and net earnings for six months of $3,410,659 or $1.33 per share, for the periods ending June 30, 2025. NORTH DALLAS BANK & TRUST CO. 12900 PRESTON ROAD DALLAS, TEXAS | FINANCIAL HIGHLIGHTS | Three Months Ended | | | Six Months Ended | | | | --- | --- | --- | --- | --- | --- | --- | | | June 30 | | | ...

"ONAR's innovative application of AI to transform marketing for the middle market is both timely and impressive," said Gazit. "The company's recent advancements—ranging from intelligent campaign optimization to its expanding network of performance-driven agencies—position it as a next-generation leader in marketing technology. I'm excited to contribute to ONAR's continued growth, and I believe my background will help the Company scale with speed, security, and strategic insight." Prior to co-founding ThetaR ...

RT A₿del ∞/21M (@dimahledba)GRINTA MODE ACTIVATED.I really love the concept of grinta, it captures my current mood perfectly and the mindset I want to see more of in @StarkWareLtd and the @Starknet ecosystem.Grinta means grit, determination, resolve. But those translations don't capture the full fire of it. It's more like a barbaric energy that unleashes insane power, the force that keeps you playing through injury, beyond your limits. It transcends you.I've got that grinta now, more than ever, because I wa ...

Core Insights - Garrett Motion Inc. (GTX) is expected to report second-quarter 2025 results on July 24, with earnings per share (EPS) estimated at 37 cents and revenues at $918 million, indicating a year-over-year growth of 32.14% in EPS and a 3.15% increase in revenues [1][2][7] Financial Performance - In Q1 2025, GTX reported an adjusted EPS of 30 cents, surpassing the Zacks Consensus Estimate of 29 cents, and net sales of $878 million, exceeding the estimate of $843 million, although the top line fell 4% year-over-year [2][4] - The adjusted EBIT margin improved to 14.9% in Q1 2025 from 13.2% in Q1 2024, reflecting the benefits of strategic cost-saving measures [4] Market Demand and Growth - The company is experiencing increased demand for turbocharged range-extended electric vehicles (EVs) and plug-in hybrids, securing new contracts in China and North America [3] - New commercial vehicle program wins in Europe and China are also contributing to the company's growth [3] Capital Expenditure - GTX anticipates capital expenditure to be 2.8% of sales in 2025, up from 2.6% in 2024, which may impact cash flow in the short term despite supporting long-term growth [4][7] Earnings Prediction - The current Earnings ESP for GTX is 0.00%, indicating no expected earnings beat, although it holds a Zacks Rank of 2 [5][6]

AI For Cybersecurity Is Advancing, But Users Need To Trust It https://t.co/gByFOlvDVB https://t.co/yHy30KiIck ...

US companies are starting to blame tariffs for their bankruptcies, but to many economists and analysts, the blame game doesn’t hold up — at least not yet https://t.co/KXKi7i2vZb ...

Let's talk about why we're losing the luxury of waiting. Have we lost that already. No, I think we have.And like I said last night, the headline numbers for the labor market, what we're seeing are okay, but it's like when you get underneath and start looking at the data. The private sector is not doing as well as everybody thinks it is. Most of the half of the employment growth we saw last month was in the public sector.And that means the private sector is not doing particularly well. So I was just joking t ...

Key Takeaways EQT will report Q2 2025 earnings on July 22, with EPS estimated at $0.45, up 662.5% from last year. Revenues are projected at $1.81B, suggesting a 52.97% increase from the year-ago quarter. Lower hedging, pipeline limits, and Olympus integration costs may weigh on EQT's performance.EQT Corporation (EQT) is set to report second-quarter 2025 results on July 22, after the closing bell.In the last reported quarter, its adjusted earnings of $1.18 cents per share beat the Zacks Consensus Estimate ...

Key Takeaways KO is expected to post Q2 revenues of $12.6B, up 1.9% YoY, but EPS may dip 1.2% to 83 cents. Favorable price/mix and digital investments are likely to support revenues despite volume weakness. Currency headwinds and soft demand in key markets may weigh on KO's margin and EPS performance.The Coca-Cola Company (KO) is slated to report second-quarter 2025 earnings on July 22, before the opening bell. The company is expected to register year-over-year top-line growth when it posts second-quarter ...

Core Insights - Rising prescription drug costs are a significant concern in healthcare, with pharmacy benefit managers (PBMs) under scrutiny for their management of drug benefits [1] - CVS Health's Caremark has secured a five-year contract with CalPERS, replacing OptumRx, to provide outpatient prescription drug benefits to nearly 587,000 members starting January 1, 2026 [2][8] - CVS Caremark was chosen for its ability to offer more affordable drug benefits and strong contract terms, including a $250 million risk for failing to meet cost control and clinical quality targets [3][8] Company Developments - CVS Caremark will manage formulary changes for CalPERS, promoting affordability in drug coverage, including weight management medications, potentially saving clients 10-15% annually [4][8] - CVS shares have increased by 6.3% over the past year, contrasting with a 17.7% decline in the industry [7] - The stock is trading at a forward one-year price-to-earnings ratio of 9.60, below the industry average of 14.00, and has a Value Score of A [9] Industry Trends - The global PBM market is growing, with CVS Caremark, OptumRx, and Express Scripts leading the market [5] - Elevance Health reported a 33% year-over-year increase in CarelonRx operating gains, driven by higher prescription volumes and recent acquisitions [5] - Humana has partnered with Epic to integrate health plan information into MyChart, enhancing access for Medicare Advantage members [6] Financial Outlook - Analyst estimates for CVS Health's earnings in 2025 and 2026 show an upward trend, with current estimates for the next year at $7.00 per share [10][11] - CVS currently holds a Zacks Rank 1 (Strong Buy), indicating positive market sentiment [11]